Legislation is being updated to allow prescribers, in certain circumstances, to issue prescriptions for up to 12-months of medication.
Prescribers will decide what prescription length is clinically appropriate for each patient. This could be a shorter or longer period, depending on individual needs.
These changes, along with updates to IT systems (including PMS and pharmacy systems), are coming into effect on 1 February 2026.
Pinnacle held two meetings for prescribers in late October to discuss the upcoming legislative changes. (Webinar recording and presentation slides linked below).
Key discussion points included:
During an RNZCGP webinar held 8 December 2025, it was clarified that patients will be charged once for a 12-month prescription at the pharmacy, but only supplied 3 months of medication at the most. There will be no changes to controlled drug amounts (1 month) or the oral contraception (6 months).
Patients will need to pick up all their prescriptions from the same pharmacy over the 12-month period, a new pharmacy means a new prescription is needed.
If medications are changed during the 12-month period, it is the responsibility of the person who gave the 12-month prescription to inform the pharmacy of the changes.
This page will be updated as more information and resources become available.
A recent audit of prescription errors across 68 pharmacies in Te Manawa Taki highlights the vital role pharmacists play in keeping patients safe. In his latest blog post, Dr Jo Scott-Jones reflects on the findings and shares key takeaways for general practice teams on reducing errors and improving communication.
Read moreTe Kaunihera Manapou | Paramedic Council is consulting on the potential introduction of designated prescribing authority for paramedics in Aotearoa New Zealand. Under the proposal, only registered paramedics who complete an approved postgraduate prescribing qualification, and meet additional requirements, would be able to prescribe medicines. A strong response to the consultation will help capture the full range of views on paramedic prescribing.
Read moreThis programme provides funding for Aclasta infusions for eligible patients. The infusion is to be provided in the community by the patient’s general practice.
View detailsThe PEP Talk in July 2020 on polypharmacy challenged us to identify actions we would take to help reduce the burden of medications on our populations.